SUBSCRIBE
SUBSCRIBE
News   Business

Oxygen Biotherapeutics, Inc. Names New Chief Financial Officer

September 25, 2008 | 
1 min read
COSTA MESA, Calif.--(BUSINESS WIRE)--Oxygen Biotherapeutics, Inc. (OTCBB:OXBO) today announced the appointment of Charles H. Seeman as the company’s chief financial officer and executive vice president finance and administration.
People
Tenax Therapeutics
MORE ON THIS TOPIC
Creative pattern made with a syringe on pastel pink background. Vaccine for Coronavirus infection. Pandemic concept.
Vaccines
Sales of Merck’s 4-Way Measles Vaccine Take Hit as US Dips Into Stockpile
April 24, 2025
 · 
2 min read
 · 
Annalee Armstrong
Roche's tower in Shanghai, China
Tariffs
Roche in ‘Very, Very Good Position’ To Weather Trump Tariffs but M&A May Suffer
April 24, 2025
 · 
2 min read
 · 
Tristan Manalac
New York City, New York United States - August 29 2021: NASDAQ, National Association of Securities Dealers Automated Quotations corporate logo sign near Times Square.
IPO
Swiss ADC Biotech Takes SPAC Track to NASDAQ
April 23, 2025
 · 
1 min read
 · 
Annalee Armstrong
Creative sketch collage of business people handshake gesture approval project development success colleagues cooperation support.
Deals
Genentech Offers up to $765M in Biobucks to Repertoire for I&I Drug Discovery
April 23, 2025
 · 
1 min read
 · 
Dan Samorodnitsky